1.
Kumari N, Dwivedi RC, Singh KK, Yadav SK, Kumar D, Singh DP. Effect of ramucirumab on progression free survival and quality of life in conventional drug resistant or metastatic non-squamous variant of non-small cell lung cancers: a pilot study. Int Surg J [Internet]. 2025 Jan. 28 [cited 2025 Oct. 25];12(2):191-7. Available from: https://www.ijsurgery.com/index.php/isj/article/view/10813